Menú
banner-risc-cardiovascular

Publicaciones

Euglycemic ketoacidosis in a non-diabetic patient with Duchenne muscular dystrophy on dapagliflozin

A. GUTIÉRREZ-BAENA, M. MATEU, P. SCHLEGEL and S. CLOTET-VIDAL
Internal and Emergency Medicine. 2025 Sep 1; . doi:10.1007/s11739-025-04058-3; PMID:40889029

Ver más:
Erectile Dysfunction in Patients with Mental Disorders: Challenges in Diagnosis and Intervention from a Family Medicine Perspective

C. CORONELL, L. DE MIGUEL, I. CONTRERAS, O. PASCUAL, L. BELLO, A. FERRANDEZ and P. GUERRERO
EUROPEAN PSYCHIATRY. 2025 Aug 26; . doi:10.1192/j.eurpsy.2025.2297;

Ver más:
Assessing TDApp: An AI-based clinical decision support system for ADHD treatment recommendations

E. BAYKOVA, I. RAYA, C. LOMBARDÍA, B. GONZALVO, I. ANDREU, D. LOSADA, T. FALKENHAIN, R. CUNILL, D. SERRANO, D. RIGAU, D. RAMÍREZ-SACO, B. LÓPEZ and X. CASTELLS
Frontiers in Psychiatry. 2025 Aug 22; . doi:10.3389/fpsyt.2025.1582746; PMID:40917247

Ver más:
Monitoring the Safety of mRNA-1273 COVID-19 Vaccine in the General Population: Results of a Regulator-mandated Post-authorisation Safety Study in Denmark, Norway, Spain, and the United Kingdom (EUPAS44273)

S. SORUP, T. RASMUSSEN, C. FRY, F. VILLALOBOS, M. ZIDAN, M. VAN WILLIGEN, D. MORRIS, A. LUPATTELLI, C. BISSACCO, L. WANG, A. ALSEMA, S. LANE, A. DESALEGN, D. ROY, M. FAR, D. ESPOSITO, S. ST LAURENT, L. ZHU, V. URDANETA, M. EMILEBACKER, H. SORENSEN and V. EHRENSTEIN
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
DARWIN EU®-Antipsychotic Prescribing in the General Population in Europe: A Descriptive Analysis of Trends and Patient Characteristics

W. WANG, M. DU, E. BURN, T. SALLES, A. PALOMAR-CROS, A. GIULIODORI, K. VERHAMME, D. VOJINOVIC, G. JADHAV, E. BR UNER, A. JEZIDZIC, E. BRADASEVIC, D. PRIETO-ALHAMBRA and M. PINEDA-MONCUSI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
DARWIN EU®-Characterisation and Survival of Elderly with Recurrent Falls in Europe

A. MENDEZ, G. JADHAV, M. CAVLINA, A. DELMESTRI, T. DUARTE-SALLES, A. GIULIODORI, P. IVANKO, A. JEZIDZIC, I. KACZMARCZYK, T. LEHTONEN, I. SÁNCHEZ, T. NIEMEN, H. OMULO, M. SVAJDA, K. VERHAMME, J. BRASH and D. VOJINOVIC
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
DARWIN EU®-Incidence of Erectile Dysfunction, Insomnia, and Hypertension in Incident Migraine and by Prophylactic Treatment initiation, Including CGRP Antagonists

J. POLITI, G. INBERG, T. NIEMEN, T. WAHLFORS, J. BRASH, I. KACZMARCZYK, D. VOJINOVIC, J. VUKOVIC, G. SANF LIX-GIMENO, F. SANCHEZ-SAEZ, T. SALLES and K. VERHAMME
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
Clinical Course and Outcomes of Myocarditis/ Pericarditis Cases following Mrna-1273 Vaccination Compared to Cases not following COVID-19 Vaccination: Interim Analysis of a VAC4EU Cohort Study

L. ZWIERS, F. VAN DER VELDEN, S. ST LAURENT, D. ESPOSITO, L. ZHU, V. URDANETA, M. EMILEBACKER, D. WEIBEL, A. LUPATTELLI, A. DESALEGN, M. ZIDAN, V. EHRENSTEIN, J. WHELER, F. VILLALOBOS, C. BISSACCO, D. MORRIS, C. FRY, A. URCHUEGUIA, M. HERRERO-SILVESTRE, M. JANSEN, D. GROBBEE and D. ONG
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
Effectiveness and Waning of the Fourth Dose Mrna COVID-19 Vaccines for the Prevention of Severe COVID-19 Related Outcomes

X. LI, N. MERCADÉ-BESORA, A. LAM, C. BARBOZA, A. DELMESTRI, T. DUARTE-SALLES, W. MAN, M. MOSSEVELD, A. PALOMAR-CROS, B. RAVENTÓS, K. VERHAMME, A. JODICKE and M. CATALÀ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:
Monitoring safety of Moderna COVID-19 vaccines in pregnancy: A multi-database study in Denmark, Norway, Spain and the United Kingdom. A regulator-mandated postauthorisation safety study in the VAC4EU network (EUPAS44450)

V. EHRENSTEIN, M. ZIDAN, C. FRY, F. VILLALOBOS, C. BURANELLI, A. LUPATTELLI, D. MORRIS, M. FAR, A. DESALEGN, S. LANE, C. BISSACCO, D. ROY, X. FANG, L. WANG, D. ESPOSITO, S. ST LAURENT, L. ZHU, V. URDANETA, M. EMILEBACKER, H. SORENSEN and S. SORUP
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Ver más:

Patronato

Colaboradores

Acreditaciones